Form 13-F position report

INTEGRA LIFESCIENCES HLDGS

Reported by COMERICA BANK

IART 0.5 08/15/25 CUSIP 457985AM1 Manager CIK 0000901541

First reported at 508,002 shares this quarter.

New
% of reported 13F value 0 This manager · Q2 2023
Shares 508,002 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 1 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-06-30 0
2023-09-30 2736
2023-12-31 2817
2024-03-31 1906
2024-06-30 1883
2024-09-30 4745
2024-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for INTEGRA LIFESCIENCES HLDGS held by COMERICA BANK.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 0 -5,000 (-100.0%) 0 $0 2025-02-14
Q3 2024 Added 5,000 +3,000 (150.0%) < 0.01% $4,745 2024-11-14
Q2 2024 Unchanged 2,000 0 (0.0%) < 0.01% $1,883 2024-08-15
Q1 2024 Reduced 2,000 -1,000 (-33.3%) < 0.01% $1,906 2024-05-16
Q4 2023 Unchanged 3,000 0 (0.0%) < 0.01% $2,817 2024-02-14
Q3 2023 Reduced 3,000 -505,002 (-99.4%) < 0.01% $2,736 2023-11-21
Q2 2023 New 508,002 +508,002 (0.0%) 0 $0 2023-08-22

Who else reported the position

82 managers reported INTEGRA LIFESCIENCES HLDGS for Q2 2023.

Managers reporting INTEGRA LIFESCIENCES HLDGS in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Invesco Ltd Unchanged 58,000,000 0 0.01% $52,954,000 10 qtrs
HIGHBRIDGE CAPITAL MANAGEMENT LLC Added 54,248,000 +5,500,000 2.19% $49,653,737 9 qtrs
Linden Advisors LP New 32,000,000 +32,000,000 0.31% $29,278,335 1 qtr
Citigroup Inc Added 26,602,000 +1,975,000 0.02% $24,287,626 10 qtrs
MACKAY SHIELDS LLC Reduced 26,274,000 -221,000 0.67% $24,083,322 10 qtrs
Aequim Alternative Investments LP Reduced 25,000,000 -10,000,000 0.86% $22,950,000 8 qtrs
AVIVA PLC Unchanged 24,625,000 0 0.09% $22,453,518 9 qtrs
JPMorgan Chase & Co Reduced 23,134,000 -254,000 < 0.01% $21,174,781 10 qtrs
CAPSTONE INVESTMENT ADVISORS LLC Reduced 22,000,000 -5,000,000 0.1% $20,196,000 10 qtrs
DLD Asset Management LP Added 17,711,000 +1,535,000 1.77% $16,255,571 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 22, 2023
Filing type
13F-HR
Position type
CON

Voting authority reported

Sole
0
Shared
0
None
508,002

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.